Home › NDC Lookup › RxCUI directory › RxCUI 850455

Darunavir 150 MG Oral Tablet — RxCUI 850455

RxNorm drug concept · Semantic clinical drug
RxCUI 850455 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI850455
Official nameDarunavir 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)3,800 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darunavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — darunavir really does need ritonavir to work properly. On its own, your body breaks darunavir down too quickly for it to control HIV. Ritonavir slows that breakdown, which kee...
  • Why do I have to take ritonavir with my darunavir — can't I just take darunavir alone?
  • Yes, it really does. Taking darunavir tablets with food increases how much the drug gets into your bloodstream by about 40% compared to taking it on an empty stomach. So the instru...
  • Does it matter whether I take darunavir with food?
📖 Read our full Darunavir guide →

🕸️ Concept Web — How Darunavir 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Darunavir 150 MG Oral Tablet RxCUI 850455

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Darunavir 460132
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prezista 643075
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Darunavir Oral Tablet 643073
    • Darunavir Oral Product 1157184
    • Darunavir Pill 1157185
    • Darunavir Oral Tablet [Prezista] 643077
    • Prezista Oral Product 1177658
    • Prezista Pill 1177659
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Darunavir 150 MG SCDC · 850454
  • Darunavir Oral Tablet SCDF · 643073
  • Darunavir Oral Product SCDG · 1157184
  • Darunavir Pill SCDG · 1157185

Brand-Name Concepts

  • Darunavir 150 MG Oral Tablet [Prezista] SBD · 850457
  • Darunavir 150 MG [Prezista] SBDC · 850456
  • Darunavir Oral Tablet [Prezista] SBDF · 643077
  • Prezista Oral Product SBDG · 1177658
  • Prezista Pill SBDG · 1177659
  • Prezista BN · 643075

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 850455 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59676-0562-01 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-562-01) PREZISTA Janssen Products LP 2008-03-08
59676-0563-01 480 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-563-01) PREZISTA Janssen Products LP 2009-01-14
59676-0564-01 240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01) PREZISTA Janssen Products LP 2009-04-27
59676-0565-01 1 BOTTLE, GLASS in 1 CARTON (59676-565-01) / 200 mL in 1 BO... PREZISTA Janssen Products LP 2011-12-16
59676-0566-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-566-30) PREZISTA Janssen Products LP 2012-11-09
Observed labelers: Janssen Products LP (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.